Ensoma
PrivateLast Round
VC Round
Sep 22, 2025
Total Funding Raised
$255M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ensoma is a biotechnology company that develops in vivo genomic medicine to engineer blood and immune cells for disease treatment using innovative vectors for direct gene modification.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ensoma Comparables
Compare Ensoma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alaya.bio | 88% | |
| Abintus Bio | 83% | |
| Gilead Sciences | 83% |
Ensoma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 22, 2025 | ||||
| Series B Extension | May 16, 2023 | ||||
| Series B | Jan 5, 2023 | ||||
| Series A | Feb 11, 2021 |
Ensoma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SymBiosis Capital Management | VC Round, Series B Extension, Series A, Series B |
| Mirae Asset | VC Round, Series B |
| Bioluminescence Ventures | Series B, Series B Extension |
| Cormorant Asset Management | VC Round, Series A, Series B |
| F-Prime Capital | Series A, Series B |
| Arix Bioscience | Series B Extension, Series B |
| 5AM Ventures | VC Round, Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 40% MoM, reaching 6.5K.
- Oct 3, 2025
Presenting new preclinical data at the Society for Immunotherapy of Cancer Annual Meeting.
Recent news
Latest coverage and updates
- decreases_headcount_byAug 7, 2026
Ensoma decreased headcount by 37 on Nov 1st '25.
Ensoma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ensoma's valuation, stock price, and market status.
Is Ensoma a public or private company?
Ensoma is a private company.
What is the current stock price of Ensoma?
Ensoma is a private company, so its shares have no public market price. Caplight tracks Ensoma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ensoma worth (valuation)?
Valuation information for Ensoma is not publicly available.
Can I buy Ensoma stock?
Ensoma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ensoma's last funding round?
Ensoma's most recent funding round was VC Round on September 22, 2025.
Who are the main investors in Ensoma?
Key investors in Ensoma include Bioluminescence Ventures, Arix Bioscience, 5AM Ventures.
Will Ensoma IPO soon?
No public IPO plans have been announced for Ensoma.
How can I track Ensoma secondary market activity?
Caplight tracks bids, offers, and trades in Ensoma's shares on secondary markets.